Featured Editorial
Nitroso Impurities In Valsartan: How Did We Miss Them?
 
By Ketan Agravat, OMSAV Pharma Research

The EMA and the FDA reported a major issue regarding the detection of a genotoxic impurity, NDMA (N-nitrosodimethylamine), and subsequently NDEA (N-nitrosodiethylamine), in lots of valsartan, an API used to manufacture generic angiotensin receptor blockers. The API at issue was supplied by two Chinese companies and was later discovered in API manufactured by an Indian manufacturer.

Industry Insights
Whatman Paper Filtration 101 – Part 2: Properties Of Cellulose Paper
Article | By Giles Barton, GE Healthcare Life Sciences

Read Part 2 of this series on cellulose filter paper to explore how different properties can influence the filter paper choice for your application.

The Role Of IoT And Control Technologies In Water Filtration Systems
White Paper | By C. Correia, N. Ventress, L. Escobar-Ferrand, and S. O’Grady, Festo Corporation

Filtration and separation technologies are the core of water treatment processes, and in many cases, they can be critical process bottlenecks. 

Solutions
Scientific Search: Intelligent Knowledge Management
Dassault Systèmes BIOVIA
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.